VCEL

#2057
Vericel Corporation
35.1400 USD
+2.03%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
35.1400
35.1400
年范围
28.9500
43.0000
日变化
+2.03%
每月变动
+7.17%
6个月变化
-3.33%
年变化
-3.33%
前一天收盘价
34.4400
开盘价
35.1400
买价
卖价
最低价
35.1400
High
35.1400
交易量
65
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 1.7838 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
112.53
市销率
6.8

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

新闻